August 29, 2025

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a 52-Week Volatile Range with Strategic Insights

Fortrea Holdings Inc. (FTRE), a compelling player in the Biotechnology sector, operates within the Healthcare industry and is headquartered in Durham, North Carolina. Specializing as a..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 187.93% Upside in the Biotechnology Sector

Sana Biotechnology, Inc. (SANA), a pioneering force in the biotechnology sector, has attracted significant investor interest due to its ambitious approach to utilizing engineered cells as..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A Biotech Gem with Over 111% Upside Potential

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, is making waves in the healthcare sector due to its innovative approach to treating severe autoimmune and..

GH Research PLC (GHRS) Stock Analysis: A Bold Biotech Bet with 137% Upside Potential

GH Research PLC (NASDAQ: GHRS) is attracting considerable attention in the biotechnology sector, with a striking potential upside of 137.15% according to analysts. This Dublin-based clinical-stage..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a Potential 211.75% Upside for Investors

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising name in the biotechnology sector, is drawing significant attention from investors with a remarkable potential upside of 211.75%. Specializing..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unpacking a 254.66% Potential Upside in the Biotech Sector

Vir Biotechnology, Inc. (NASDAQ: VIR) stands out in the biotechnology sector with an impressive potential upside of 254.66%, according to analyst ratings. This San Francisco-based clinical-stage..

Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling a 13.15% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, is catching the attention of investors with its substantial potential upside of..

Savara, Inc. (SVRA) Stock Analysis: Exploring a Remarkable 155% Upside Potential in the Biotech Sector

For investors hunting for promising opportunities in the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) presents a compelling case with its significant potential upside. With a market..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 75% Potential Upside in the Biotech Arena

Maze Therapeutics, Inc. (NASDAQ: MAZE) is making significant waves in the biotechnology sector, promising investors substantial growth opportunities. With its focus on developing precision medicines, Maze..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a 30% Revenue Growth

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector, specifically within the medical care facilities industry, operates senior housing communities across the United..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Biotechnology Innovator with a 255% Potential Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the healthcare sector, specifically within the biotechnology industry. Based in Cambridge, Massachusetts, Relay Therapeutics is a clinical-stage..

Claritev Corporation (CTEV) Stock Analysis: Navigating the Ups and Downs of a Promising Healthcare Player

Claritev Corporation (NASDAQ: CTEV) has emerged as a notable player in the healthcare sector, specializing in health information services. With a market capitalization of $1.17 billion,..

Immatics N.V. (IMTX) Stock Analysis: A Promising Biotech with 158% Potential Upside

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Germany, has been gaining attention in the investment community for its innovative approach to cancer treatment...

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Diagnostic Innovations Amidst Market Volatility

Myriad Genetics, Inc. (NASDAQ: MYGN) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of..

Precigen, Inc. (PGEN) Stock Analysis: Unraveling an 81% Upside Potential in Biotechnology

Investors keen on the biotechnology sector should pay close attention to Precigen, Inc. (NASDAQ: PGEN), a discovery and clinical-stage biopharmaceutical company with a market capitalization of..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Exploring a Remarkable 244.58% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology industry with a compelling investment narrative, particularly for those following the healthcare sector. With a market..

Bicycle Therapeutics (BCYC) Stock Analysis: Unpacking a 237.7% Potential Upside in Biotech

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering entity in the biotechnology sector, has captured investor attention with a staggering potential upside of 237.7%. This UK-based clinical-stage..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating Challenges with a 23% Upside Potential

Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare sector, operates as a comprehensive healthcare solutions provider, catering to a broad array of medical..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a 230% Potential Upside in Biotech Innovations

Investors in the biotechnology sector are keeping a keen eye on REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotech firm that’s making waves with its promising pipeline..

Search

Funds

August 29, 2025

Search

Funds

August 29, 2025

FTSE 100

Funds